4 Quin 0.5% w/v Eye Drop

Medically reviewed by Dr. Naresh Dang | Written By Sonu Kumar Rao

Last updated on: November 02, 2020 10:50 am

4 Quin 0.5% w/v Eye Drop

Uses of 4 Quin 0.5% w/v Eye Drop

4 Quin 0.5% w/v Eye Drop is used for the treatment or prevention of the following disease(s):

Various Bacterial Infections

Side effects of 4 Quin 0.5% w/v Eye Drop

The most common side effects of 4 Quin 0.5% w/v Eye Drop are – Dizziness, Headache, Dry Eyes, Insomnia, Fever, Conjunctivitis, Diarrhea, Dyspepsia, Nausea, Vomiting, Increased Lacrimation, Keratitis, Ocular Discomfort, Pain, Abdominal Pain,Constipation, Abnormal Liver Function

These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.

Precautions while using 4 Quin 0.5% w/v Eye Drop

Do not use 4 Quin 0.5% w/v Eye Drop if you are allergic to – Moxifloxacin

If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using 4 Quin 0.5% w/v Eye Drop.

If you are allergic to any medicine or food, consult your doctor before using this medicine.

Use this medicine under the supervision of your doctor.

To avoid an adverse reaction, consult your doctor if you are already taking other medicines.

How 4 Quin 0.5% w/v Eye Drop works

4 Quin 0.5% w/v Eye Drop contains – Moxifloxacin

Moxifloxacin interferes with action of enzymes needed for bacterial replication. Inhibits topoisomerases I (DNA gyrase) and IV, impairing bacterial DNA replication, transcription, repair, and recombination.

Dosage of 4 Quin 0.5% w/v Eye Drop

The dosage of 4 Quin 0.5% w/v Eye Drop depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.

Please use this medicine as prescribed by your doctor.

Overdose of 4 Quin 0.5% w/v Eye Drop

If you forget to take a dose of 4 Quin 0.5% w/v Eye Drop, do not take two doses at the same time, there is a risk of overdose.

If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.

Precautions & Warnings

Alcohol

Information will be added soon.

Pregnancy

Information will be added soon.

Breastfeeding

Information will be added soon.

Driving

Information will be added soon.

Kidney

Information will be added soon.

Liver

Information will be added soon.

Interaction

Drug :- Aluminum hydroxide, aluminum-magnesium hydroxide, calcium carbonate, didanosine, magnesium hydroxide, multivitamins, products containing zinc: May interfere with GI absorption of moxifloxacin. Give moxifloxacin 4 hours before or 8 hours after these products.

Class IA antiarrhythmics (procainamide, quinidine), class III antiarrhythmics (amiodarone, sotalol): May increase risk of cardiac arrhythmias. Avoid using together.

Drugs that prolong QT interval (antipsychotics, erythromycin, TCAs): May have additive effect. Avoid using together.

Live-virus vaccines: May decrease effectiveness of live-virus vaccines. Don't give live-virus vaccines during therapy.

NSAIDs: May increase risk of CNS stimulation and seizures. Monitor patient and adjust treatment as needed.

Black Box Warning

Steroids: May increase risk of tendinitis and tendon rupture. Monitor patient for tendon pain or inflammation.

Sucralfate: May decrease absorption of moxifloxacin, reducing anti-infective response. If use together can't be avoided, give at least 6 hours apart.

Warfarin: May increase anticoagulant effects. Monitor PT and INR closely.

About Reviewer

Dr. Naresh Dang is an MD in Internal Medicine. He has special interest in the field of Diabetes, and has over two decades of professional experience in his chosen field of specialty. Dr. Dang is an expert in the managememnt of Diabetes, Hypertension and Lipids. He also provides consultation for Life Style Management.

About Author

Sonu Kumar is a registered pharmacist with Bihar State Pharmacy Council with over 6 months experience. He is a medicine content contributor at Zotezo.

ZOTEZO IN THE NEWS

...